Treatment of alopecia in transgender men is more challenging for a dermatologist, but there are alternatives available that will not interfere with hormone treatment. Androgenetic alopecia is a problem that affects many men, including transgender men, especially those undergoing hormone therapy. While finasteride is often the first choice for treating androgenetic alopecia in transgender men, it does not always prove to be the best solution. In this article, we’ll take a look at why finasteride may not be suitable for everyone, and what alternative methods – such as topical finasteride or mesotherapy with dutasteride – may be more effective and safer.
Androgenetic alopecia in transsexual men has its own specific conditions. Hair loss is caused by dihydrotestosterone (DHT), which is formed from testosterone under the influence of the enzyme 5-alpha-reductase. In transgender men who frequently take hormones as part of their therapy, testosterone and DHT levels can be elevated and can affect hair follicles, especially if they are genetically susceptible. Finasteride, a popular drug for treating androgenetic alopecia, works by blocking the 5-alpha-reductase type II enzyme, which reduces DHT levels by about 60-70%. While it is effective in many people, transgender men may experience specific challenges with its use, such as interactions with hormone therapy and side effects that can affect their well-being.
One reason finasteride is not always the best choice for treating androgenetic alopecia in transgender men is its potential side effects. Finasteride can cause impaired libido or gynecomastia, which can be particularly problematic for transgender men who are already struggling to adjust their bodies to their gender identity. Additionally, oral finasteride has a systemic effect, meaning it affects the entire body, not just the scalp. Therefore, it is worth considering alternative treatments for androgenetic alopecia that minimize the risk of side effects and better suit their individual needs.
One such alternative is topical finasteride, which is gaining popularity for the treatment of androgenetic alopecia in men and women. Unlike the oral form of the drug, topical finasteride is applied directly to the scalp, allowing for a concentrated action at the site of the problem – that is, around the hair follicles. This significantly reduces the risk of systemic side effects, such as hormonal disruption or libido problems. Studies indicate that topical finasteride can effectively reduce DHT levels in the scalp, while minimizing the impact on the rest of the body. For transgender men who want to avoid additional hormonal changes, topical finasteride may be a much safer option for treating androgenetic alopecia.
Another effective alternative to finasteride is mesotherapy with dutasteride, a modern approach to treating androgenetic alopecia in transsexual men. Dutasteride, unlike finasteride, blocks both types of the 5-alpha-reductase enzyme (types I and II), reducing DHT levels by up to 90%. This makes dutasteride potentially more effective in inhibiting hair loss, especially in advanced stages of baldness.
In mesotherapy, dutasteride is administered directly into the scalp using fine needles, which allows for precise action at the site of the problem. As a result, the drug does not enter the bloodstream to any significant degree, minimizing the risk of systemic side effects such as those seen with oral use of finasteride or dutasteride. Mesotherapy with dutasteride for the treatment of androgenetic alopecia is especially recommended for those who can’t tolerate oral medications well or are otherwise unable to take them.
Mesotherapy with dutasteride has another advantage – its effects are long-lasting, and treatments do not need to be performed frequently. Typically, a series of treatments every 2-4 weeks for several months is sufficient, followed by booster sessions once every 2 months. What’s more, mesotherapy with dutasteride can be combined with other ingredients, such as biotin or vitamins, which further strengthen the hair and improve its condition. This comprehensive approach can not only curb hair loss, but also stimulate the growth of new, healthier hair.
Alternative medications such as minoxidil are another option to consider for treating androgenetic alopecia in transgender men. Minoxidil, applied topically at concentrations of 2% or 5%, works by stimulating hair follicles and improving blood supply to the scalp, which promotes new hair growth. Unlike finasteride, minoxidil does not affect hormone levels, making it a safe choice for transgender men who are concerned about interactions with hormone therapy.
However, minoxidil requires regular use – once application is discontinued, hair may begin to fall out again. For those who cannot tolerate minoxidil in the form of a rub due to skin irritation, low-dose oral minoxidil may be an alternative, although its use should also be consulted with a doctor.
For the treatment of androgenetic alopecia in transsexual men, platelet-rich plasma (PRP) therapy is also worth considering. This method involves injecting plasma taken from the patient’s blood, which is rich in growth factors, into the scalp. PRP stimulates hair follicles, extends the hair growth phase and can inhibit baldness. It is an option that is particularly attractive to transgender men because it does not affect hormones and is all-natural. PRP therapy for the treatment of androgenetic alopecia can be combined with other methods, such as mesotherapy with dutasteride, for even better results.
Research
Research on the treatment of androgenetic alopecia in transgender men consists mainly of general approaches to androgenetic alopecia, with less specific data for this group. An example is the Journal of Drugs in Dermatology article Finasteride in Transgender Men for Hair Loss, which discusses the use of finasteride in transgender individuals, pointing out the potential risk of interactions with hormone therapy, particularly in the context of decreased libido or gynecomastia. Research suggests that finasteride may be less effective in transgender men on testosterone therapy because their hormone profile differs from cisgendered men, requiring a case-by-case approach.
Treatment of alopecia in transgender men – summary
In conclusion, treatment of androgenetic alopecia in transgender men need not be limited to finasteride, which, while effective, is not always the best choice. Alternatives such as topical finasteride, mesotherapy with dutasteride, minoxidil or platelet-rich plasma therapy offer effective and safe solutions that can be tailored to individual needs. The key is to consult a dermatologist, who will help you choose the right method, taking into account your hormone therapy and overall health. Don’t wait – if you’re noticing symptoms of baldness in yourself, schedule a consultation and find out what androgenetic alopecia treatment options will work best for you.
You can read more about hair transplantation HERE. If the problem concerns you, we invite you to CONTACT us. You can also schedule a visit ON-LINE. Visit us on Instagram and TikTok.
